Skip to main content

Advertisement

Log in

Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases

  • CUTTING EDGE IN AUTOIMMUNITY
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is defined by buds of granulation tissue within lung distal airspaces. The diagnosis requires the histopathologic evidence of organizing pneumonia along with a suggestive clinical and radiographic pattern. This disorder is characterized by a good response to corticosteroids and an excellent prognosis. It can occur in association with a broad spectrum of clinical conditions or can be isolated, in this last case named cryptogenic organizing pneumonia. We searched for BOOP in patients with autoimmune rheumatic diseases (ARD) in the literature, and we found 32 well-documented cases. We reported here demographic features, manifestations, treatment and outcome of patients with BOOP associated with ARD. Notably, BOOP can be the presenting feature in some patients with ARD; thus, a close follow-up of patients with BOOP is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28:422–46.

    Article  PubMed  Google Scholar 

  2. Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med. 2008;3:67–75.

    Article  PubMed  Google Scholar 

  3. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001;161:158–64.

    Article  CAS  PubMed  Google Scholar 

  4. King TE. Cryptogenic organizing pneumonia. In: www.uptodate.com. 2013. http://www.uptodate/contents/cryptogenic-organizing-pneumonia/contributors. (Accessed 14 Jan 2014).

  5. Sveinsson OA, Isakson HJ, Gudmundsson G. Organising pneumonia—a review and results from Icelandic studies. Laeknabladid. 2008;94:27–35.

    PubMed  Google Scholar 

  6. Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltim). 1995;74:201–11.

    Article  CAS  Google Scholar 

  7. Roos JC, Chilvers ER, Ostor AJ. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy. J Rheumatol. 2007;34:238–9.

    PubMed  Google Scholar 

  8. Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol. 2006;33:1189–93.

    PubMed  Google Scholar 

  9. Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, et al. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum. 2011;41:256–64.

    Article  CAS  PubMed  Google Scholar 

  10. Ostör AJ, Chilvers ER, Somerville MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol. 2006;33:622–8.

    PubMed  Google Scholar 

  11. Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int. 2012;32:1055–7.

    Article  CAS  PubMed  Google Scholar 

  12. Sakaida H, Komase Y, Takemura T. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Mod Rheumatol. 2010;20:611–6.

    Article  PubMed  Google Scholar 

  13. Ikegawa K, Hanaoka M, Ushiki A, Yamamoto H, Kubo K. A case of organizing pneumonia induced by tocilizumab. Intern Med. 2011;50:2191–3.

    Article  CAS  PubMed  Google Scholar 

  14. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis. 1991;50:956–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Weber F, Prior C, Kowald E, Schmuth M, Sepp N. Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus. Br J Dermatol. 2000;143:453–5.

    Article  CAS  PubMed  Google Scholar 

  16. Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med. 1997;91:175–7.

    Article  CAS  PubMed  Google Scholar 

  17. Kondoh Y, Taki F, Ando M, et al. A case of bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis who responded to corticosteroid and immunosupressant therapy. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:1165–70.

    CAS  PubMed  Google Scholar 

  18. Shinohara T, Hidaka T, Matsuki Y, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med. 1997;36:519–23.

    Article  CAS  PubMed  Google Scholar 

  19. Koinuma D, Miki M, Ebina M, et al. Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med. 2002;41:26–9.

    Article  PubMed  Google Scholar 

  20. Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxf). 2003;42:371–4.

    Article  CAS  Google Scholar 

  21. Yáñez VJ, Cisternas MM, Saldías HV, Saldías PF. Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case. Rev Med Chile. 2009;137:88–93.

    Article  Google Scholar 

  22. Laszlo A, Espolio Y, Auckenthaler A, Michel JP, Janssens JP. Azathioprine and low-dose corticosteroids for the treatment of cryptogenic organizing pneumonia in an older patient. J Am Geriatr Soc. 2003;51:433–4.

    Article  PubMed  Google Scholar 

  23. Lee YH, Choi SJ, Ji JD, Shim JJ, et al. Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia. Korean J Intern Med. 2000;15:85–8.

    CAS  PubMed  Google Scholar 

  24. Strobel ES, Bonnet RB, Werner P, Schaefer HE, Peter HH. Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis. Clin Rheumatol. 1998;17:246–9.

    Article  CAS  PubMed  Google Scholar 

  25. Yoo JW, Song JW, Jang SJ, Lee CK, et al. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia. Rheumatology (Oxf). 2011;50:932–8.

    Article  Google Scholar 

  26. Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 1994;149:1670–5.

    Article  CAS  PubMed  Google Scholar 

  27. Knoell KA, Hook M, Grice P, Hendrix JD. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J Am Acad Dermatol. 1999;40:328–30.

    Article  CAS  PubMed  Google Scholar 

  28. Chan WM, Lau CS, Wang E, Peh WC. Anti-Jo-1 syndrome presenting as cryptogenic organizing pneumonia. Respir Med. 1995;89:639–41.

    Article  CAS  PubMed  Google Scholar 

  29. Henriet AC, Diot E, Marchand-Adam S, et al. Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren’s syndrome. Eur Respir Rev. 2010;19:161–3.

    Article  CAS  PubMed  Google Scholar 

  30. Takada H, Saito Y, Nomura A, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus. Pediatr Pulmonol. 2005;40:257–60.

    Article  PubMed  Google Scholar 

  31. Gammon RB, Bridges TA, Al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992;102:1171–4.

    Article  CAS  PubMed  Google Scholar 

  32. Kalenian M, Zweiman B. Inflammatory myopathy, bronchiolitis obliterans organizing pneumonia and anti-Jo-1 antibodies an interesting association. Clin Diagn Lab Immunol. 1997;4:236–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  33. Shimizu Y, Tsukagoshi H, Nemoto T, et al. Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. Rheumatol Int. 2002;22:216–8.

    Article  PubMed  Google Scholar 

  34. Taylor JG, Bolster MB. Bronchiolitis obliterans with organizing pneumonia associated with scleroderma and scleroderma spectrum diseases. J Clin Rheumatol. 2003;9:239–45.

    Article  PubMed  Google Scholar 

  35. Otsuka F, Amano T, Hashimoto N, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med. 1996;35:341–4.

    Article  CAS  PubMed  Google Scholar 

  36. Krishnappriya R, Gupta R, Christopher DJ, Balamugesh T, James P. Bronchiolitis obliterans organising pneumonia in systemic lupus erythematosus with anti-phospholipid antibody syndrome—an unusual presentation. Clin Respir J. 2010;4:125–6.

    Article  PubMed  Google Scholar 

  37. Hsue YT, Paulus HE, Coulson WF. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with long term survival. J Rheumatol. 1993;20:877–9.

    CAS  PubMed  Google Scholar 

  38. Imasaki T, Yoshi A, Tanaka S, et al. Polymyositis and Sjögren’s syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med. 1996;35:231–5.

    Article  CAS  PubMed  Google Scholar 

  39. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997;90:227–30.

    Article  CAS  PubMed  Google Scholar 

  40. Xing M, Lansdale TF, McNamara CF, et al. Bronchiolitis obliterans with organizing pneumonia (BOOP) heralding anti-Jo-1-positive polymyositis. J Clin Rheumatol. 1999;5:219–23.

    Article  CAS  PubMed  Google Scholar 

  41. Devos FG, Leleu O, Aubry P, Jounieaux V. Bronchiolitis obliterans organizing pneumonia associated with dermatomyositis and antiphospholipid syndrome. Rev Mal Respir. 2002;19:249–51.

    Google Scholar 

  42. Park SH, Kum YS, Kim KC, et al. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29:1231–5.

    Article  PubMed  Google Scholar 

  43. Mane F, Mets T, Vzncken W, et al. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner’s cystitis. Chest. 1993;104:642–4.

    Article  Google Scholar 

  44. Lambert M, Hebbar M, Viget N, et al. Bronchiolite oblitkante avec pneumopathie organike: une complication rare du syndrome de Gougerot–Sjiigren primitive. M Rev MCd Interne. 2000;21:74–7.

    Article  CAS  Google Scholar 

  45. Ioannou S, Toya SP, Tomos P, Tzelepis GE. Cryptogenic organizing pneumonia associated with primary Sjogren’s syndrome. Rheumatol Int. 2008;28:1053–5.

    Article  PubMed  Google Scholar 

  46. Nakamura H, Kita J, Kawakami A, et al. Multiple bone fracture due to Fanconi’s syndrome in primary Sjögren’s syndrome complicated with organizing pneumonia. Rheumatol Int. 2009;30:265–7.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Doria.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rojas, C.M.L., Borella, E., Palma, L. et al. Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases. Immunol Res 61, 97–103 (2015). https://doi.org/10.1007/s12026-014-8607-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-014-8607-z

Keywords

Navigation